Reimbursement
A code is not coverage. Coverage is not payment.
Why coding strategy, coverage strategy, and collections must be planned as three separate problems for novel assays.
Coming soon
Insights
What we're seeing across reimbursement and commercialization.
Short, practical perspectives from the work — written for operators, founders, and reimbursement leaders.
In progress
Perspectives currently in preparation.
Regulation
Operating through evolving federal diagnostic regulation
How laboratories and assay developers can build durable CLIA, quality, and documentation practices while federal oversight of laboratory-developed tests continues to evolve.
Coming soon
Commercialization
Launch readiness before the first claim
The validation, documentation, coding, and billing alignment that determines whether a launch produces revenue or rework.
Coming soon
Regulatory and coverage policy for diagnostics continues to change. Nothing here should be read as legal, regulatory, or reimbursement advice for a specific program — that work happens inside an engagement.
Begin the conversation